Cotinus coggygria Scop. Attenuates Acetic Acid-Induced Colitis in Rats by Regulation of Inflammatory Mediators.
Ali SenBüşra ErtaşOzge CevikAybeniz YıldırımDamla Gökçeoğlu KayalıDilek AkakinLeyla BitişGoksel SenerPublished in: Applied biochemistry and biotechnology (2023)
In traditional medicine, many medicinal plants are used in the treatment of various diseases caused by inflammation. The objective of the present study is to elucidate for the first time the effects of Cotinus coggygria (CC) ethanol extract (CCE) on colonic structure and inflammation of acetic acid-induced ulcerative colitis in rats. Colonic damage was assessed using disease activity index score, enzyme-linked immunosorbent assay, and hematoxylin-eosin staining. Also, in vitro antioxidant activity of CCE was investigated by ABTS methods. Total phytochemical content of CCE was measured spectroscopically. Acetic acid caused colonic damage according to disease activity index and macroscopic scoring. CCE significantly reversed these damages. While the levels of proinflammatory cytokines TNF-alpha, IL-1beta, IL-6, and TGF-1beta increased in tissue with UC, IL-10 level decreased. CCE increased inflammatory cytokine levels to values close to the sham group. At the same time, while markers indicating disease severity such as VEGF, COX-2, PGE2, and 8-OHdG indicated the disease in the colitis group, these values returned to normal with CCE. Histological research results support biochemical analysis. CCE exhibited significant antioxidant against ABTS radical. Also, CCE was found to have a high content of total polyphenolic compounds. These findings provide evidence that CCE might be benefit as a promising novel therapy in the treatment of UC in humans due to high polyphenol content and justify the use of CC in folkloric medicine for treatment of inflamed diseases.
Keyphrases
- disease activity
- oxidative stress
- rheumatoid arthritis
- ulcerative colitis
- systemic lupus erythematosus
- ankylosing spondylitis
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- clinical trial
- single cell
- epithelial mesenchymal transition
- anti inflammatory
- transforming growth factor
- mesenchymal stem cells
- high throughput
- endothelial cells
- bone marrow
- flow cytometry
- high resolution
- mass spectrometry
- vascular endothelial growth factor